Enzalutamide
Anti-Androgens
Sold as XTANDI
- Drug class
- Anti-Androgens
- Availability
- See label
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 38
Overview
Enzalutamide is an active pharmaceutical ingredient in the Anti-Androgens group (L02BB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 30 | May 29, 2026 |
| CA Canada | Health Canada | 5 | May 20, 2026 |
| EU European Union | EMA | 3 | March 26, 2026 |
GBUnited Kingdom· MHRA
30 products
Uses
1). 1). 1). • for the treatment of adult men with metastatic CRPC whose disease has progressed on or after docetaxel therapy.
How to take
CACanada· Health Canada
5 products
Uses
4 Geriatrics (≥ 65 years of age) 05/2024 TABLE OF CONTENTS Certain sections or subsections that are not applicable at the time of the preparation of the most recent authorized product monograph are not listed. RECENT MAJOR LABEL CHANGES ............................................................................................
2 TABLE OF CONTENTS ............................................................................................................. 2 PART 1: HEALTHCARE PROFESSIONAL INFORMATION .............................................................
5 1 INDICATIONS.................................................................................................................... 1 Pediatrics ............................................................................................................................
2 Geriatrics ............................................................................................................................ 5 2 CONTRAINDICATIONS .......................................................................................................
EUEuropean Union· EMA
3 products
Uses
1). 1). 1). 1). • for the treatment of adult men with metastatic CRPC whose disease has progressed on or after docetaxel therapy.
How to take
Drug interactions
Known interactions involving Enzalutamide. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 546. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL068310442 · revised May 29, 2026
- [2]Health Canada (DPD) · 02494736 · revised May 20, 2026
- [3]European Medicines Agency · EMEA/H/C/002639 · revised March 26, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.